Finance

The stock has returned more than 2,500% by insuring what others won’t.

These three stocks not only generate copious amounts of free cash flow, but also have the potential to continue paying higher dividends over time.

This stock can grant investors two benefits (growth and dividends) for the price of one.

Intellia Therapeutics’ innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.

These three funds might appeal to investors looking for diversification and passive income.

Prologis’ accelerating earnings growth bodes well for its ability to continue increasing its dividend at a brisk pace.

There’s no need to stick with a plan that isn’t meeting your needs to the fullest.

Why these three consumer stocks are must buys at current prices.

There’s still plenty of time for opportunistic income investors to take advantage of both lifts.

Annaly Capital could end up a winner if rates keep falling, but dividend investors still shouldn’t buy it. Here’s what you need to know.

Griffin aggressively added to his hedge fund’s positions in all three of these top AI stocks in Q2.

Claiming early has its drawbacks, but one of them is about to get a little easier to manage next year.

If you earn a large paycheck, you may not be happy about this news.

KMI earnings call for the period ending September 30, 2024.

PLD earnings call for the period ending September 30, 2024.

ABT earnings call for the period ending September 30, 2024.

SYF earnings call for the period ending September 30, 2024.

The company’s upcoming report could be an eventful one.

These chipmakers are battling for supremacy in AI.

The Dow Jones Industrial Average is comprised of 30 stocks, but one stands out from the pack.